Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28999305 | 1.00 | MAPT (0.45) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL15874977 | 1.00 | MAPT (0.45) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL30320209 | 0.97 | MAPT (0.41) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL28999176 | 0.93 | MAPT (0.41) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL3241633 | 0.90 | MAPT (0.45) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL14230548 | 0.90 | MAPT (0.45) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL28999170 | 0.90 | — | — | |
| SCHEMBL24926247 | 0.89 | MAPT (0.52) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL19853017 | 0.89 | MAPT (0.52) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL18725210 | 0.89 | MAPT (0.52) | MAPTLMNADNM1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023115459-A1 | TUMOR ANTIGEN/MHC-I COMPLEX, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 青岛华赛伯曼医学细胞生物有限公司 | 2023-06-29 | — | — | WO | disclosed |